| Current status and future perspectives on MRNA drug manufacturing C Webb, S Ip, NV Bathula, P Popova, SKV Soriano, HH Ly, B Eryilmaz, ... Molecular pharmaceutics 19 (4), 1047-1058, 2022 | 67 | 2022 |
| Nanobodies: the future of antibody-based immune therapeutics NV Bathula, H Bommadevara, JM Hayes Cancer biotherapy & radiopharmaceuticals 36 (2), 109-122, 2021 | 48 | 2021 |
| Delivery vehicles for self-amplifying RNA NV Bathula, P Popova, A Blakney Messenger RNA therapeutics, 355-370, 2022 | 7 | 2022 |
| Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity NV Bathula, JJ Friesen, IC Casmil, CJ Wayne, S Liao, SKV Soriano, ... Journal of Controlled Release 374, 28-38, 2024 | | 2024 |
| An Ultrahydrating Polymer that Protects Protein Therapeutics and RNA‐Lipid Nanoparticles Against Freezing, Heat and Lyophilization Stress A Herrmann, S Abbina, NV Bathula, PMM Nouri, I Chafeeva, ... Advanced Functional Materials, 2406878, 2024 | | 2024 |
